146 related articles for article (PubMed ID: 20034125)
1. Cellular evaluation of synthesized insulin/transferrin bioconjugates for oral insulin delivery using intelligent complexation hydrogels.
Shofner JP; Phillips MA; Peppas NA
Macromol Biosci; 2010 Mar; 10(3):299-306. PubMed ID: 20034125
[TBL] [Abstract][Full Text] [Related]
2. Novel delivery system based on complexation hydrogels as delivery vehicles for insulin-transferrin conjugates.
Kavimandan NJ; Losi E; Peppas NA
Biomaterials; 2006 Jul; 27(20):3846-54. PubMed ID: 16529810
[TBL] [Abstract][Full Text] [Related]
3. Novel complexation hydrogels for oral peptide delivery: in vitro evaluation of their cytocompatibility and insulin-transport enhancing effects using Caco-2 cell monolayers.
Ichikawa H; Peppas NA
J Biomed Mater Res A; 2003 Nov; 67(2):609-17. PubMed ID: 14566804
[TBL] [Abstract][Full Text] [Related]
4. The effect of complexation hydrogels on insulin transport in intestinal epithelial cell models.
Wood KM; Stone GM; Peppas NA
Acta Biomater; 2010 Jan; 6(1):48-56. PubMed ID: 19481619
[TBL] [Abstract][Full Text] [Related]
5. Wheat germ agglutinin functionalized complexation hydrogels for oral insulin delivery.
Wood KM; Stone GM; Peppas NA
Biomacromolecules; 2008 Apr; 9(4):1293-8. PubMed ID: 18330990
[TBL] [Abstract][Full Text] [Related]
6. Cellular evaluation of insulin transmucosal delivery.
López JE; Peppas NA
J Biomater Sci Polym Ed; 2004; 15(4):385-96. PubMed ID: 15212324
[TBL] [Abstract][Full Text] [Related]
7. Complexation hydrogels for oral protein delivery: an in vitro assessment of the insulin transport-enhancing effects following dissolution in simulated digestive fluids.
Perakslis E; Tuesca A; Lowman A
J Biomater Sci Polym Ed; 2007; 18(12):1475-90. PubMed ID: 17988515
[TBL] [Abstract][Full Text] [Related]
8. Thiol functionalized polymethacrylic acid-based hydrogel microparticles for oral insulin delivery.
Sajeesh S; Vauthier C; Gueutin C; Ponchel G; Sharma CP
Acta Biomater; 2010 Aug; 6(8):3072-80. PubMed ID: 20144748
[TBL] [Abstract][Full Text] [Related]
9. Development of PEGDMA: MAA based hydrogel microparticles for oral insulin delivery.
Kumar A; Lahiri SS; Singh H
Int J Pharm; 2006 Oct; 323(1-2):117-24. PubMed ID: 16828246
[TBL] [Abstract][Full Text] [Related]
10. PEGylated insulin loaded complexation hydrogels for protected oral delivery.
Coolich MK; Lanier OL; Cisneros E; Peppas NA
J Control Release; 2023 Dec; 364():216-226. PubMed ID: 37890591
[TBL] [Abstract][Full Text] [Related]
11. Cyclodextrin complexed insulin encapsulated hydrogel microparticles: An oral delivery system for insulin.
Sajeesh S; Bouchemal K; Marsaud V; Vauthier C; Sharma CP
J Control Release; 2010 Nov; 147(3):377-84. PubMed ID: 20727924
[TBL] [Abstract][Full Text] [Related]
12. Combination Strategy with Complexation Hydrogels and Cell-Penetrating Peptides for Oral Delivery of Insulin.
Fukuoka Y; Khafagy ES; Goto T; Kamei N; Takayama K; Peppas NA; Takeda-Morishita M
Biol Pharm Bull; 2018; 41(5):811-814. PubMed ID: 29709919
[TBL] [Abstract][Full Text] [Related]
13. Complexation hydrogels for intestinal delivery of interferon beta and calcitonin.
Kamei N; Morishita M; Chiba H; Kavimandan NJ; Peppas NA; Takayama K
J Control Release; 2009 Mar; 134(2):98-102. PubMed ID: 19095021
[TBL] [Abstract][Full Text] [Related]
14. Facilitated nanoscale delivery of insulin across intestinal membrane models.
Woitiski CB; Sarmento B; Carvalho RA; Neufeld RJ; Veiga F
Int J Pharm; 2011 Jun; 412(1-2):123-31. PubMed ID: 21501675
[TBL] [Abstract][Full Text] [Related]
15. In vitro release behavior and stability of insulin in complexation hydrogels as oral drug delivery carriers.
Kim B; Peppas NA
Int J Pharm; 2003 Nov; 266(1-2):29-37. PubMed ID: 14559391
[TBL] [Abstract][Full Text] [Related]
16. Surface-functionalized polymethacrylic acid based hydrogel microparticles for oral drug delivery.
Sajeesh S; Bouchemal K; Sharma CP; Vauthier C
Eur J Pharm Biopharm; 2010 Feb; 74(2):209-18. PubMed ID: 19737614
[TBL] [Abstract][Full Text] [Related]
17. Complexation hydrogels for oral insulin delivery: effects of polymer dosing on in vivo efficacy.
Tuesca A; Nakamura K; Morishita M; Joseph J; Peppas N; Lowman A
J Pharm Sci; 2008 Jul; 97(7):2607-18. PubMed ID: 17876768
[TBL] [Abstract][Full Text] [Related]
18. Development of a P((MAA-co-NVP)-g-EG) Hydrogel Platform for Oral Protein Delivery: Effects of Hydrogel Composition on Environmental Response and Protein Partitioning.
Steichen S; O'Connor C; Peppas NA
Macromol Biosci; 2017 Jan; 17(1):. PubMed ID: 27689827
[TBL] [Abstract][Full Text] [Related]
19. Assessment of poly(methacrylic acid-co-N-vinyl pyrrolidone) as a carrier for the oral delivery of therapeutic proteins using Caco-2 and HT29-MTX cell lines.
Carr DA; Peppas NA
J Biomed Mater Res A; 2010 Feb; 92(2):504-12. PubMed ID: 19213059
[TBL] [Abstract][Full Text] [Related]
20. SEDDS for intestinal absorption of insulin: Application of Caco-2 and Caco-2/HT29 co-culture monolayers and intra-jejunal instillation in rats.
Liu J; Werner U; Funke M; Besenius M; Saaby L; Fanø M; Mu H; Müllertz A
Int J Pharm; 2019 Apr; 560():377-384. PubMed ID: 30790612
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
